Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Health Canada/DIORSKIN STAR

Authorized

STANDARD

DIORSKIN STAR

parfums christian dior🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: e9b7dcbd1fde7e2c
Company: parfums christian dior
Type: Standard

Approval Details

Approval Id: e9b7dcbd1fde7e2c
Drug Approval Canada Name: DIORSKIN STAR
Product Name: DIORSKIN STAR
Status: Cancelled Post Market
Status Date: 2018-08-02
Original Market Date: 2016-03-18
Din: 02447339
Drug Class: Human
Dosage Form: Liquid
Route Of Administration: Topical
Schedule: OTC
Ahfs: 84:80.00
Atc Original: D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name: d 02 ba 30
Aig Number: 0216790146
Company Name: parfums christian dior
Company Address: 33 Avenue Hoche, Paris, --, France, 75008

Active Ingredients

TITANIUM DIOXIDE

3.5 % / W/W

OCTINOXATE

6 % / W/W

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

e9b7dcbd1fde7e2c

Type

Standard

Back to Health Canada Approvals

DIORSKIN STAR - Health Canada Drug Approval Details